Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.
A questionnaire based on a hypothetical 6-day-old infant exposed to a sibling with varicella was mailed to 316 Pediatric Infectious Diseases Society members to determine their recommendations for administration of varicella zoster immunoglobulin (VZIG). Of the 137 faculty members who responded 20% would recommend VZIG for the infant described (13% were undecided). When further information including a negative maternal history for varicella, prematurity or maternal varicella infection occurring 1 week after delivery was considered, the numbers who recommended VZIG (43, 46 and 52%, respectively) rose significantly (P less than 0.01). Twenty-two physicians had knowledge of a severe case of varicella following postnatal exposure. Only 33% of faculty members surveyed feel there are no indications for VZIG in infants exposed after 48 hours of age.
D002487:Centers for Disease Control and Prevention, U.S.; D002644:Chickenpox / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007231:Infant, Newborn; D010372:Pediatrics; D012955:Societies, Medical; D011795:Surveys and Questionnaires; D014481:United States
D007106:Immune Sera; C030799:varicella-zoster immune globulin